Dena Battle, president of KCCure, presents a survey of over 500 patients from 16 different countries on issues around COVID-19 and kidney cancer treatment. The results showed that the pandemic is causing high levels of anxiety among patients with kidney cancer and that 70% of these patients believed they were at a higher risk of COVID-19 infection. Drs. Tom Powles and Brian Rini weigh in on the issues raised in these findings.